These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 15714165)

  • 1. CD4(+) T-cell-mediated mechanisms of corneal allograft rejection: role of Fas-induced apoptosis.
    Hegde S; Beauregard C; Mayhew E; Niederkorn JY
    Transplantation; 2005 Jan; 79(1):23-31. PubMed ID: 15714165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD4+ T-cell-independent rejection of corneal allografts.
    Niederkorn JY; Stevens C; Mellon J; Mayhew E
    Transplantation; 2006 Apr; 81(8):1171-8. PubMed ID: 16641604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fas-mediated cytotoxicity is not required for rejection of murine nonvascularized heterotopic cardiac allografts.
    Djamali A; Odorico JS
    Transplantation; 1998 Dec; 66(12):1793-801. PubMed ID: 9884278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of Fas-Fas ligand interactions in the immunorejection of allogeneic mouse corneal transplants.
    Yamagami S; Kawashima H; Tsuru T; Yamagami H; Kayagaki N; Yagita H; Okumura K; Gregerson DS
    Transplantation; 1997 Oct; 64(8):1107-11. PubMed ID: 9355824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T cell subsets in the immune rejection of murine heterotopic corneal allografts.
    Matoba AY; Peeler JS; Niederkorn JY
    Invest Ophthalmol Vis Sci; 1986 Aug; 27(8):1244-54. PubMed ID: 2942516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute cardiac allograft rejection by directly cytotoxic CD4 T cells: parallel requirements for Fas and perforin.
    Grazia TJ; Plenter RJ; Weber SM; Lepper HM; Victorino F; Zamora MR; Pietra BA; Gill RG
    Transplantation; 2010 Jan; 89(1):33-9. PubMed ID: 20061916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential roles of CD8+ and CD8- T lymphocytes in corneal allograft rejection in 'high-risk' hosts.
    Niederkorn JY; Stevens C; Mellon J; Mayhew E
    Am J Transplant; 2006 Apr; 6(4):705-13. PubMed ID: 16539627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prolongation of corneal allograft survival by CTLA4-FasL in a murine model.
    Shi W; Chen M; Xie L
    Graefes Arch Clin Exp Ophthalmol; 2007 Nov; 245(11):1691-7. PubMed ID: 17541621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of CD4+ T cells in immunobiology of orthotopic corneal transplants in mice.
    Yamada J; Kurimoto I; Streilein JW
    Invest Ophthalmol Vis Sci; 1999 Oct; 40(11):2614-21. PubMed ID: 10509657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contribution of Fas ligand to cardiac allograft rejection.
    Seino K; Kayagaki N; Bashuda H; Okumura K; Yagita H
    Int Immunol; 1996 Sep; 8(9):1347-54. PubMed ID: 8921411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of Fas ligand as an effector molecule in corneal graft rejection.
    Stuart PM; Yin X; Plambeck S; Pan F; Ferguson TA
    Eur J Immunol; 2005 Sep; 35(9):2591-7. PubMed ID: 16114107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD8+ T cell-mediated delayed rejection of orthotopic guinea pig cornea grafts in mice deficient in CD4+ T cells.
    Higuchi R; Streilein JW
    Invest Ophthalmol Vis Sci; 2003 Jan; 44(1):175-82. PubMed ID: 12506072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute rejection of allografted CTL-susceptible leukemia cells from perforin/Fas ligand double-deficient mice.
    Nomi H; Tashiro-Yamaji J; Yamamoto Y; Miura-Takeda S; Miyoshi-Higashino M; Takahashi T; Azuma H; Ueda H; Katsuoka Y; Kubota T; Yoshida R
    J Immunol; 2007 Aug; 179(4):2180-6. PubMed ID: 17675477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are corneal cells susceptible to antibody-mediated killing in corneal allograft rejection?
    Hargrave SL; Mayhew E; Hegde S; Niederkorn J
    Transpl Immunol; 2003; 11(1):79-89. PubMed ID: 12727479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. B7-H1-induced apoptosis as a mechanism of immune privilege of corneal allografts.
    Hori J; Wang M; Miyashita M; Tanemoto K; Takahashi H; Takemori T; Okumura K; Yagita H; Azuma M
    J Immunol; 2006 Nov; 177(9):5928-35. PubMed ID: 17056517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alloantigen-driven T cell death mediated by Fas ligand and tumor necrosis factor-alpha is not essential for the induction of allograft acceptance.
    Wagener ME; Konieczny BT; Dai Z; Ring GH; Lakkis FG
    Transplantation; 2000 Jun; 69(11):2428-32. PubMed ID: 10868653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD95 ligand expression on corneal epithelium and endothelium influences the fates of orthotopic and heterotopic corneal allografts in mice.
    Osawa H; Maruyama K; Streilein JW
    Invest Ophthalmol Vis Sci; 2004 Jun; 45(6):1908-15. PubMed ID: 15161857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FasL is important in costimulation blockade-resistant skin graft rejection.
    Trambley J; Lin A; Elwood E; Bingaman AW; Lakkis F; Corbascio M; Pearson TC; Larsen CP
    Transplantation; 2001 Feb; 71(4):537-43. PubMed ID: 11258433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preliminary findings in corneal allograft rejection in patients with keratoconus.
    Hargrave S; Chu Y; Mendelblatt D; Mayhew E; Niederkorn J
    Am J Ophthalmol; 2003 Apr; 135(4):452-60. PubMed ID: 12654360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytotoxic pathways in the skin allograft rejection by CD4+ T cells.
    Ito A; Minagawa M; Tomiyama K; Ito M; Kawai K
    Transplantation; 1999 Jul; 68(1):97-100. PubMed ID: 10428275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.